Anavex Life Sciences Capital Expenditures (CapEx) Growth & History (AVXL)

Anavex Life Sciences's capital expenditures (capex) was $3,015 for fiscal 2014.

View full Anavex Life Sciences company overview

Anavex Life Sciences annual capital expenditures (capex) history

Anavex Life Sciences annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20142014-09-30$3,015$3,015
20132013-09-30$0$0
20122012-09-30$0$0
20112011-09-30$0−$3,310
20102010-09-30$3,310

Anavex Life Sciences capital expenditures (capex) trends

Between the periods ended 2010-09-30 and 2014-09-30, Anavex Life Sciences's capital expenditures (capex) decreased from $3,310 to $3,015, a change of −$295. The latest reported quarter, Q3 2015, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Anavex Life Sciences source filings ↗

Community posts

It’s quiet here.

No posts about AVXL yet. Start the conversation.

Write the first post